Important Updates On Some Prominent MDL Drug Lawsuits
Updates on several prominent drug MDL’s including Actos, Granuflo, Risperdal and Xarelto:
Actos Bladder Cancer Lawsuits continue to be filed
As the $2.7 billion Actos Bladder Cancer settlement lumbers towards completion, after being announced a year ago, comes new court data that shows that more plaintiffs are filing bladder cancer and wrongful death claims against Takeda the manufacturer …
Beshear filed lawsuit against nation’s largest kidney dialysis provider
() – Attorney General Andy Beshear has filed a consumer protection lawsuit against Fresenius Medical Care Holdings Inc. for deceptive marketing practices.
Fresenius is accused in the lawsuit of promoting its kidney dialysis product, GranuFlo, as …
Xarelto Lawsuit Update: Discovery & Trial Selection
Over the past few years, hundreds of individuals affected by the anticoagulant Xarelto have sued Bayer/Johnson & Johnson, claiming that the drug company failed to warn individuals about the potential serious bleeding risks associated with the drug.
— Top Class Actions (@TopClassActions) November 24, 2016
Risperdal Case Settles Before Trial Begins
Parties have settled a lawsuit over claims that the antipsychotic drug Risperdal caused a young man to grow excessive breast tissue that had been set to start trial Monday.
The case N.F. v. Janssen Pharmaceuticals settled for a confidential sum last week.
— Lawsuit Update (@lawsuit_update) November 29, 2016
Fifth Risperdal Case Ends in Settlement Before Trial
The most recent Risperdal lawsuit slated to go before a jury ended in a settlement before the trial even began.
Risperdal manufacturer Johnson & Johnson agreed to settle the case for an undisclosed amount, possibly avoiding another massive …
— TheGoldwaterLawFirm (@GoldwaterLaw) November 25, 2016
Please follow and like us: